<DOC>
	<DOCNO>NCT02805881</DOCNO>
	<brief_summary>Safety Feasibility Combined Trigeminal Occipital Transcutaneous Nerve Stimulation ( CTO-TNS ) Major Depressive Disorder ( MDD )</brief_summary>
	<brief_title>Safety Feasibility Combined Trigeminal Occipital Transcutaneous Nerve Stimulation ( CTO-TNS ) Major Depressive Disorder ( MDD )</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<criteria>The subject capable understanding study sign inform consent . Subject age 18 65 year old . Unipolar major depressive disorder Score Hamilton Depression Rating Scale ( HDRS21 ) &gt; 22 Current MDD episode &gt; 3 month Nonresponse &gt; 6 week use one six antidepressant current episode History neurosurgical intervention . Subjects metal implant shrapnel head , except dental implant . Skin lesion inflammation region stimulate electrode . Pregnancy Lactation . Women reproductive age use efficient contraceptive method . History cerebrovascular event . Psychotic bipolar depression History schizophrenia , schizoaffective disorder nonmood disorder psychosis Current delirium , dementia , amnestic disorder cognitive disorder Clinically significant current suicidal intent assess investigator team . Obsessivecompulsive disorder posttraumatic stress disorder Alcohol nonalcohol psychoactive substance abuse dependence Significant cardiac , medical , progressive neurological medical illness An implantable electrical device pacemaker .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>